Keyphrases
Whole Blood
100%
Hodgkin Lymphoma
100%
Plasma Epstein-Barr Virus DNA
100%
Prognostic Marker
100%
Event-free Survival
30%
Quantitative PCR
20%
Chemotherapy
20%
Overall Survival
20%
Epstein-Barr Virus
20%
Significant Predictors
20%
Newly Diagnosed
10%
Old Age
10%
Advanced Stage
10%
Peripheral Blood
10%
Asian Patients
10%
Epstein-Barr Virus-encoded RNA
10%
International Prognostic Index
10%
Hemoglobin Level
10%
Human Hemoglobin
10%
Prognostic Role
10%
Low Serum Albumin
10%
Serum Albumin Level
10%
DNA Quantification
10%
Survival Outcomes
10%
Extranodal Sites
10%
Korean Patients
10%
Clinical Outcomes
10%
RNA Fluorescence in Situ Hybridization (RNA-FISH)
10%
Medicine and Dentistry
Virus DNA
100%
Hodgkin's Lymphoma
100%
Epstein Barr Virus
100%
Event Free Survival
23%
Chemotherapy
15%
Overall Survival
15%
Real Time Polymerase Chain Reaction
15%
Prevalence
7%
Serum Albumin
7%
In Situ Hybridization
7%
Pharmacology, Toxicology and Pharmaceutical Science
Epstein-Barr Virus
100%
Hodgkin Disease
100%
Virus DNA
100%
Event Free Survival
23%
Chemotherapy
15%
Overall Survival
15%
Prevalence
7%
Serum Albumin
7%
Immunology and Microbiology
Epstein Barr Virus
100%
DNA Virus
100%
Event Free Survival
23%
Real Time Polymerase Chain Reaction
15%
Overall Survival
15%
Prevalence
7%
Hemoglobin Blood Level
7%
Albumin Level
7%
In Situ Hybridization
7%